Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: Setting a new standard
10.4155/fsoa-2017-0050
Saved in:
| Main Authors: | , , , , |
|---|---|
| Other Authors: | |
| Format: | Review |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/178715 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-178715 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1787152024-11-13T22:03:02Z Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: Setting a new standard Vellayappan, B.A Halasz, L.M Knisely, J.P Chang, E.L Lo, S.S MEDICINE bevacizumab lomustine methylated DNA protein cysteine methyltransferase temozolomide cancer growth cancer radiotherapy clinical trial (topic) elderly care glioblastoma human methylation multimodality cancer therapy overall survival priority journal randomized controlled trial (topic) Review 10.4155/fsoa-2017-0050 Future Science OA 3 3 FSO210 2020-10-21T08:05:29Z 2020-10-21T08:05:29Z 2017 Review Vellayappan, B.A, Halasz, L.M, Knisely, J.P, Chang, E.L, Lo, S.S (2017). Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: Setting a new standard. Future Science OA 3 (3) : FSO210. ScholarBank@NUS Repository. https://doi.org/10.4155/fsoa-2017-0050 20565623 https://scholarbank.nus.edu.sg/handle/10635/178715 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031 |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
bevacizumab lomustine methylated DNA protein cysteine methyltransferase temozolomide cancer growth cancer radiotherapy clinical trial (topic) elderly care glioblastoma human methylation multimodality cancer therapy overall survival priority journal randomized controlled trial (topic) Review |
| spellingShingle |
bevacizumab lomustine methylated DNA protein cysteine methyltransferase temozolomide cancer growth cancer radiotherapy clinical trial (topic) elderly care glioblastoma human methylation multimodality cancer therapy overall survival priority journal randomized controlled trial (topic) Review Vellayappan, B.A Halasz, L.M Knisely, J.P Chang, E.L Lo, S.S Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: Setting a new standard |
| description |
10.4155/fsoa-2017-0050 |
| author2 |
MEDICINE |
| author_facet |
MEDICINE Vellayappan, B.A Halasz, L.M Knisely, J.P Chang, E.L Lo, S.S |
| format |
Review |
| author |
Vellayappan, B.A Halasz, L.M Knisely, J.P Chang, E.L Lo, S.S |
| author_sort |
Vellayappan, B.A |
| title |
Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: Setting a new standard |
| title_short |
Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: Setting a new standard |
| title_full |
Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: Setting a new standard |
| title_fullStr |
Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: Setting a new standard |
| title_full_unstemmed |
Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: Setting a new standard |
| title_sort |
combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: setting a new standard |
| publishDate |
2020 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/178715 |
| _version_ |
1821203397748981760 |